PHASE II GBM IGG ANTIBODY EIA TEST

Devices, Measure, Antibodies To Glomerular Basement Membrane (gbm)

SCIMEDX CORP.

The following data is part of a premarket notification filed by Scimedx Corp. with the FDA for Phase Ii Gbm Igg Antibody Eia Test.

Pre-market Notification Details

Device IDK011348
510k NumberK011348
Device Name:PHASE II GBM IGG ANTIBODY EIA TEST
ClassificationDevices, Measure, Antibodies To Glomerular Basement Membrane (gbm)
Applicant SCIMEDX CORP. 400 FORD RD. Denville,  NJ  07834
ContactGary Lehnus
CorrespondentGary Lehnus
SCIMEDX CORP. 400 FORD RD. Denville,  NJ  07834
Product CodeMVJ  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2001-05-02
Decision Date2001-06-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.